Literature DB >> 23185776

[Study on the diagnostic criteria for coronary heart disease patients of blood stasis syndrome].

Chang-Geng Fu1, Zhu-Ye Gao, Pei-Li Wang.   

Abstract

The diagnostic criteria of blood stasis syndrome (BBS) established by the Specialty Committee of Activating Blood Circulation and Removing Stasis, Chinese Association of Integrative Medicine 1986 has been widely used in clinical practice of Chinese medicine. But coronary heart disease (CHD) of BBS has its own features. By using clinical epidemiological methods, establishing the diagnostic criteria for CHD patients of BBS is of great significance in furthering its studies, exerting the advantages of Chinese medicine in preventing and treating CHD, and elevating the clinical efficacy.

Entities:  

Mesh：

Year:  2012        PMID： 23185776

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN： 1003-5370


  9 in total

1.  Relationship between two blood stasis syndromes and inflammatory factors in patients with acute coronary syndrome.

Authors:  Cai-Yun Ma; Jing-Hua Liu; Jian-Xun Liu; Da-Zhuo Shi; Zhen-Ye Xu; Shao-Ping Wang; Min Jia; Fu-Hai Zhao; Yue-Rong Jiang; Qin Ma; Hong-Yu Peng; Yuan Lu; Ze Zheng; Feng-Xue Ren
Journal:  Chin J Integr Med       Date:  2016-12-27       Impact factor: 1.978

2.  Associations of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms with circulating PAF-AH levels and risk of coronary heart disease or blood stasis syndrome in the Chinese Han population.

Authors:  Guo-Hua Zheng; Shang-Quan Xiong; Hai-Ying Chen; Li-Juan Mei; Ting Wang
Journal:  Mol Biol Rep       Date:  2014-07-18       Impact factor: 2.316

Review 3.  Integrative Western and chinese medicine on coronary heart disease: where is the orientation?

Authors:  Siming Li; Hao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

4.  ITIH4: A New Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease Patient Identified with Proteomic Method.

Authors:  Hao Xu; Qinghua Shang; Hao Chen; Jianpeng Du; Jianyan Wen; Geng Li; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

5.  The Optimal Cut-Off Value of Blood Stasis Syndrome Score in BSS Diagnosis in Korea.

Authors:  Byoung-Kab Kang; Tae-Yong Park; Jeeyoun Jung; Mimi Ko; Myeong Soo Lee; Ju Ah Lee
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-11       Impact factor: 2.629

6.  Integrated Modules Analysis to Explore the Molecular Mechanisms of Phlegm-Stasis Cementation Syndrome with Ischemic Heart Disease.

Authors:  Wei-Ming Xu; Kuo Yang; Li-Jie Jiang; Jing-Qing Hu; Xue-Zhong Zhou
Journal:  Front Physiol       Date:  2018-01-22       Impact factor: 4.566

7.  Effects of probucol on atherosclerotic plaque and soluble thrombomodulin in patients with coronary heart disease.

Authors:  Donghai Liu; Guoping Yang; Xuebin Zhao; Huanzhi Yang
Journal:  Exp Ther Med       Date:  2018-06-07       Impact factor: 2.447

8.  A Study on the Development of a Korean Metabolic Syndrome Questionnaire Using Blood Stasis Clinical Data.

Authors:  Byoung-Kab Kang; Soobin Jang; Mi Mi Ko; Jeeyoun Jung
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-27       Impact factor: 2.629

9.  A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol.

Authors:  Xiaoping Wu; Mingyu Yan; Xingxue Pang; Hui Wu; Zhigeng Hu; Rui Xiao; Jianlue Pan; Ying Li; Shengnan Shi; Yanping Deng; Jiaxi Li; Peili Wang; Keji Chen
Journal:  Front Cardiovasc Med       Date:  2022-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.